A trail of complaints at pharmacy linked to meningitis deaths
Records show that inspectors knew about problems with an injectable steroid produced at the New England Compounding Center going back to 2002. The same tainted drug allegedly to blame for 23 meningitis deaths. Both documents, as well as testimony before a congressional committee, suggest a pattern of violations and modest penalties for the Framingham specialty pharmacy.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers